Molecular Diagnosis of Systemic Autoinflammatory Diseases
Systemic autoinflammatory diseases (SAIDs) are a set of rare clinically and genetically heterogeneous conditions. The project proposes to identify novel genes and specific signatures in subgroups of patients with SAIDs.
| Condition(s) | Inflammatory Disease, Genetic Disease, Somatic Mutation, Molecular Sequence Variation, Molecular Pathway Deregulation |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Systemic autoinflammatory diseases (SAIDs) are a set of rare clinically and genetically heterogeneous conditions. The project proposes to identify novel genes and specific signatures in subgroups of patients with SAIDs. |
| Who can participate | Inclusion Criteria: * A patient presenting with a clinical and biological aseptic inflammatory syndrome associating one or more of the following signs: spontaneously resolving fever, abdominal (pain, diarrhea), locomotor (arthralgia, myalgia), thoracic (pain, pericarditis), cutaneous, sensory (uveitis, deafness), or renal (amyloidosis) involvement. Exclusion Criteria: * Adult subject to legal protection measures (guardianship, curatorship, safeguard of justice). |
| Ages | 1 Week to 120 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
| Locations | Paris, France |
| Start date | 2022-05-18 |
| NCT ID | NCT05364294 |
| Official listing | https://clinicaltrials.gov/study/NCT05364294 |